R
Live / Applied — New application — not yet assigned to an examiner (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 02 Apr 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99742150
- Mark type
- Design + words
- Filed
- 02 Apr 2026
- Attorney of record
- Jeffrey J. Scepanski
Goods and services
- Class 040 — Treatment of materials: Production of cell lines for use in the manufacture of biopharmaceuticals; Protein fabrication, production, and manufacture for others
- Class 042 — Scientific and technological services: Research and development of pharmaceutical products; Genetic engineering services utilizing a collection of genetic technologies for the rapid production of human antibodies; Genetic engineering services, namely, deletion and modification of genes for others, and production of genetically modified animals; Genetic research; Genetic engineering services for genes, cells, and animals using non-human embryonic stem cells (ES) and non-human embryo manipulation technology for rapid development of genetically modified non-human animals; Genetic engineering services, namely, the production of genetically-engineered antibodies for others; Genetic engineering services, namely, scientific laboratory services in the nature of the production of genetic sequences for others for scientific research and pharmaceutical research and development purposes; Scientific research in the field of genetics, genetic engineering, genetic sequencing, disease modeling, pharmacogenomics, and precision medicine; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
- Class 044 — Medical, beauty and agricultural services: Medical information; medical assistance services
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 02 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 02 Apr 2026 — NEW APPLICATION ENTERED